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sWithout question, the most striking risk association for
developing atrial fibrillation (AF) is advancing age (1).
Structural and electrophysiological changes occur in nearly
all tissue with aging. The cellular electrophysiological
changes seen with AF are understood to be of complex
etiology and accepted to be either or both cause and effect
with regard to AF. However, it has generally been accepted
both intuitively and based on prior evidence that fibrosis in
the atrium, as in the skin, is a consequence of normal
aging—wrinkles in the atrium (2–4).
See page 2225
In this issue of the Journal, Platonov et al. (5) report their
findings from a well-conducted study that questions the
accepted age and atrial fibrosis relationship. The authors
conducted meticulous histological examinations at impor-
tant sites in both atria in patients with paroxysmal AF,
permanent AF, and AF-free controls. The study was
blinded, systematic, and utilized objective computer-
assisted evaluation of fatty infiltration, inflammatory cell
count, and fibrosis. They found a twofold to threefold
increase in these changes in patients with AF compared to
controls, and the same findings were more prevalent and
extensive with permanent compared to paroxysmal AF
patients. A principal finding from this study was that no
correlation existed between age and fibrosis at any atrial
location.
Before we decide whether the findings of Platonov et al.
(5) question or refute the conventional wisdom with regard
to age and atrial fibrosis, we must critically examine their
findings in the context of the incredibly complex and
nuanced details that underpin any examination of structural
correlates with abnormal electrophysiology.
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As important as quantifying the extent of histopathological
changes with AF is the exact site of occurrence. The
investigators sampled sites with unique fiber orientation,
and thus conduction properties (crista terminalis and Bach-
mann’s bundle), and the posterior left atrium, including
closer to the pulmonary veins (PV) (6). The nature of this
meticulous study is highly labor intensive, essentially pre-
cluding widespread or even more hypothesis-driven, tar-
geted tissue sampling.
Left atrium versus right atrium. Interestingly, there was
no difference in this study between the extent of fibrofatty
changes in the right atrium (RA) and the left atrium (LA).
If we consider the 3 main explanations for fibrosis in the
atrium—namely, resulting from AF, part of the aging
process, and causing AF—and the fact that AF determina-
tion on the basis of invasive studies is likely not a RA
phenomenon, and this study shows the lack of association
with age, then AF giving rise to fibrosis remains a causative
role. As discussed in the following text, a common link
between these various phenomena may be diastolic abnor-
mality of the left ventricle, and we would expect greater
changes in the LA. However, once AF develops, perhaps it
becomes the overriding determinant of further or progres-
sive fibrotic changes.
LA versus PVs. Any study looking to evaluate the deter-
minants or associations with AF may assume that AF is a
single disease process. The ground-breaking changes initi-
ated more than a decade ago on the basis of invasive
electrophysiology trigger elimination for paroxysmal AF
(7,8). It is clear that AF is at least 2 disease entities: a
trigger-driven paroxysmal form, and a “substrate”-based
persistent form. In this context, one needs comparative,
quantitative, and temporal data between the PVs (trigger
site), PV ostia (yet an explained site of conduction delay in
patients with AF), and the atrial tissue (9,10).
LA near the inferior PV. In the study by Platonov et al.
(5), the only site-specific, time-dependent change was in the
LA at the level of the inferior PV (fibrosis, p  0.051) and
ombined count of fibrofatty change (p  0.002) (5). Why
hould a particular location show more fibrosis or fatty
hange than others? In addition to possible regional pro-
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istics of cardiac motion may play a role. Atrial fibrillation is
more common in taller persons (11) and in athletes, includ-
ing long-distance runners (12). The fulcrum for cardiac
translatory movement is the site of attachment of the
pericardium around the atrial–PV junction and may explain
relatively accelerated evidence of tissue damage at some sites
more than others.
Nerve tissue. The so-called substrate for AF includes the
atrial tissue and the autonomic tone influencing it (13,14).
The histological basis for the dysautonomia associated with
AF is unknown. Further, the recent demonstration of
interstitial Cajal-like cells in and around the atrial-PV
junctions requires histopathological characterization and
association with regionality in the structural changes seen in
patients with AF (15,16).
What Are the Structural Changes?
The investigators systematically examined for several histo-
logical abnormalities including fibrosis, fatty infiltration,
capillary density, cardiomyocyte size, and inflammatory cell
count. Importantly, fibrofatty change extent, which was as
much as 3-fold higher in patients with AF, correlated with
lymphomononuclear infiltration. Of all the possible struc-
tural changes, the 1 that appears most likely to be an
initiator of the disease process leading to AF would be the
inflammatory changes. It would be intriguing to know whether
the ratio of inflammatory to fibrotic change might help
distinguish whether such a disjoint of present can mark effects
related to AF, per se, and the aging process alone (17).
Why Do These Changes Occur?
Platonov et al. (5) have tackled in a delightfully straightfor-
ward and meticulous manner an exceedingly complex set of
conundra to try and clarify. Which came first. . .LA size
increase or fibrosis, age or AF, AF or fibrosis, inflammation or
AF, and so forth? It becomes important to consider whether a
common link between these parameters is present.
LV diastolic dysfunction. One candidate for a common
link/cause with regard to fibrosis, LA size, and AF is LV
diastolic dysfunction (DD). Much like AF, LVDD is
exceedingly common among the elderly (18), and is even
debated in terms of a normal feature of aging versus
pathology. Diastolic dysfunction leads to an increase in
atrial pressures and size, and presumably will promote
fibrosis and possibly the persistent forms of AF. There may
be, in addition, site-specific dilation of compliant structures
such as the PVs and left atrial appendage, and likely affects
the LA more than RA initially. So, is DD the age-
associated disease that underpins AF? The importance of
this entity has been recognized (19). Unfortunately, how-
ever, little is known about whether DD is a disease or itself
an explained constellation of abnormalities having an un-
identified link that distinguishes normal senescence with
pathology. dElectrophysiology and Structural Abnormalities
Any attempt at a straightforward correlation between struc-
tural abnormalities, electrocardiographic data, and arrhyth-
mogenesis, even when outstandingly conducted as the
present study is, is necessarily simplistic and possibly naïve.
Platonov et al. (5) picked sites like Bachmann’s bundle,
important for interatrial conduction. From a prior study, for
example, signal average P-wave analysis from the MADIT II
(Multicenter Automatic Defibrillator Implantation Trial II)
study data would appear to support a role for conduction
defects in developing AF. A specific P-wave morphology
suggested interatrial block in patients in whom AF devel-
oped, whereas terminal P-wave abnormalities represented
delayed conduction into the PVs and did not differ between
patients with paroxysmal AF remaining in sinus rhythm and
those with new onset AF. Although the logic is elegant,
when we consider the complexity of electropathology in-
cluding simultaneous foci and re-entry, concealed re-entry
during sinus rhythm, micro–re-entry concealed or manifest,
Wedensky facilitation, Prinzmetal phenomena, and perhaps
above all, the importance of relative changes in refractori-
ness compared to conduction abnormality, it is exceedingly
difficult to draw such simple conclusions (20–22). Diseased
tissue in the region of the PV may not show conduction
delay if there is retrograde penetration from a firing focus in
the vein and similar retrograde penetration and Wedensky
facilitation from a focus firing in the vein, and the same
phenomenon (actual pathology in the vein) would give rise
to abnormalities in the middle of the P-wave from retro-
grade concealed block affecting antegrade penetration. Al-
though dysautonomia can explain both changes in refracto-
riness and conduction, structural changes and refractoriness
have a less clearly defined relationship—even more so than
atrial flutter—and no discussion of AF arrhythmogenesis
can be complete without considering the structural basis, if
any, for abnormal refractoriness.
Context and Future Studies
Platonov et al. (5) are to be congratulated on making a
genuine contribution to our understanding of AF, age, and
structural changes. Their study was small, and the historical
collection of clinical data, including frequency of AF,
treatment, and whether patients without clinical AF actually
did not have AF, are unavoidable limitations that must,
however, temper our acceptance of the notion that age, per
se, is not the cause of atrial fibrosis.
Bigger. . . better? Although we would love to see larger
tudies with greater tissue site sampling, the present study is
n excellent example of how a relatively small study, when
ell conceived and carefully executed while being cognizant
f the need for less ambitious objectives for the study, can
ake an original and potentially ground-breaking contribu-
ion to the understanding of AF pathogenesis.
Another similar, carefully performed, small study withetailed electrophysiology determinations and tissue sam-
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with electrophysiology and histopathology providing a basis
for the changes seen with delayed-enhancement magnetic
resonance imaging (3,23,24). Once the electropathological
nature of magnetic resonance imaging changes is estab-
lished, larger, longitudinal studies with a greater mix of
patient and AF profiles would be exceedingly revealing.
AF, age, and fibrosis. Whether these entities represent
cause, effect, or epiphenomenon is unlikely to be known in
the near future. The present study by Platonov et al. (5)
represents an important stepping stone to clarify these issues
while questioning conventional wisdom regarding age and
fibrosis. The wrinkles in the atrium may not just simply go
with our gray hairs!
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